Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study

被引：0
|
作者：
Singh, Balwinder [1 ]
MahmoudianDehkordi, Siamak [1 ]
Voort, Jennifer Vande [1 ]
Han, Xianlin [1 ]
Port, John [1 ]
Frye, Mark [1 ]
Daouk, Rima Kaddurah [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
IV; Ketamine; Metabolomics Signature; Treatment; Resistant Depression; Open Label Trials;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P227
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [21] Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
    Shiroma, Paulo R.
    Albott, C. Sophia
    Johns, Brian
    Thuras, Paul
    Wels, Joseph
    Lim, Kelvin O.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (11): : 1805 - 1813
  • [22] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [23] Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression
    Liebrenz, Michael
    Stohler, Rudolf
    Borgeat, Alain
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04): : 640 - 643
  • [24] A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression
    Kumar, P. N. Suresh
    Menon, Vikas
    Andrade, Chittaranjan
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 99
  • [25] Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression A Case Report
    Bartova, Lucie
    Weidenauer, Ana
    Dold, Markus
    Naderi-Heiden, Angela
    Kasper, Siegfried
    Willeit, Matthaeus
    Praschak-Rieder, Nicole
    JOURNAL OF ECT, 2017, 33 (03) : E31 - E32
  • [26] Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: Report of two cases
    Paul, Robert
    Schaaff, Nadine
    Padberg, Frank
    Moeller, Hans-Juergen
    Frodl, Thomas
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (03): : 241 - 244
  • [27] Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Gustavo C. Leal
    Igor D. Bandeira
    Fernanda S. Correia-Melo
    Manuela Telles
    Rodrigo P. Mello
    Flavia Vieira
    Cassio S. Lima
    Ana Paula Jesus-Nunes
    Lívia N. F. Guerreiro-Costa
    Roberta F. Marback
    Ana Teresa Caliman-Fontes
    Breno L. S. Marques
    Marília L. O. Bezerra
    Alberto L. Dias-Neto
    Samantha S. Silva
    Aline S. Sampaio
    Gerard Sanacora
    Gustavo Turecki
    Colleen Loo
    Acioly L. T. Lacerda
    Lucas C. Quarantini
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 577 - 582
  • [28] Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Leal, Gustavo C.
    Bandeira, Igor D.
    Correia-Melo, Fernanda S.
    Telles, Manuela
    Mello, Rodrigo P.
    Vieira, Flavia
    Lima, Cassio S.
    Jesus-Nunes, Ana Paula
    Guerreiro-Costa, Livia N. F.
    Marback, Roberta F.
    Caliman-Fontes, Ana Teresa
    Marques, Breno L. S.
    Bezerra, Marilia L. O.
    Dias-Neto, Alberto L.
    Silva, Samantha S.
    Sampaio, Aline S.
    Sanacora, Gerard
    Turecki, Gustavo
    Loo, Colleen
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (03) : 577 - 582
  • [29] Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
    Berner, Jon
    Acharjee, Animesh
    DISCOVER MENTAL HEALTH, 2024, 4 (01):
  • [30] Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
    Barenboim, Ivan
    Lafer, Beny
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2018, 40 (01) : 110 - 110
12345